Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPLM Designation Statement: This internet enduring material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1.5 clinical hours toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.
Session Description: This session will equip participants to identify polypharmacy, consider non-pharmacologic treatment options, potentially inappropriate medications, medication interactions, the aging body (declining renal and hepatic function), patient prognosis and time to benefit, patient and family preferences, cost, and the unique regulatory and interdisciplinary team care environment of long-term care. We will then arm participants with a rational approach to deprescribing..
Recognize potentially inappropriate medications based on the Beers and STOPP lists.
Consider patient prognosis and time to benefit as well as time to harm when prescribing or deprescribing.
Describe the role of the consultant pharmacist to assist in rational deprescribing.
Implement a systematic plan to review medication lists and deprescribe unnecessary medications.
Speaker(s): Ariel Cole, MD, CMD John Fleming, MD, CMD Wendy Ethridge, PharmD, CPh Alan Obringer, RPh, CPh
Director, Geriatric Medicine Fellowship,